• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    Agios Pharmaceuticals, Inc. (AGIO)

    -NasdaqGS
    114.43 Up 4.76(4.34%) Dec 26, 4:00PM EST
    |After Hours : 114.25 Down 0.18 (0.16%) Dec 26, 7:59PM EST
    Add to Portfolio
    Prev Close:109.67
    Open:111.28
    Bid:N/A
    Ask:114.43 x 200
    1y Target Est:102.83
    Beta:1.979
    Earnings Date:Mar 4 - Mar 9 (Est.)
    Day's Range:110.71 - 115.16
    52wk Range:21.70 - 124.39
    Volume:572,307
    Avg Vol (3m):937,800
    Market Cap:3.97B
    P/E (ttm):N/A
    EPS (ttm):-1.20
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    AGIOUp 4.34%3.97B
    ALXNUp 3.04%37.18B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):66.19
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.45
    Quarterly EPS Est (Dec-14) :-0.63
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Agios Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the field of cancer metabolism and inborn errors of metabolism (IEMs) in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback